Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsConsultation-liaison psychiatry

Psych · Consultation-liaison psychiatry

Pain psychiatry and somatic symptom disorders

Also known as Somatic symptom disorder · Illness anxiety disorder · Hypochondriasis · Medically unexplained symptoms · Functional somatic syndromes · Chronic pain psychiatry · Bodily distress disorder

Exam-exhaustive fellowship topic on pain psychiatry and somatic symptom disorders for consultation-liaison practice — DSM-5-TR SSD and illness anxiety (vs ICD-11 framing), chronic pain–psych interface, PHQ-15 assessment, CBT and stepped care evidence, cautious SNRI/TCA analgesia, and opioid dual-diagnosis principles. FRANZCP-primary, globally tagged.

medium24 referencesUpdated 26 July 202613 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • New or changing focal neurological, constitutional, or red-flag pain features — re-open the organic work-up even in known somatising patients
  • Telling the patient 'it is all in your head' — destroys alliance and is nosologically wrong under DSM-5-TR SSD logic
  • Long-term high-dose opioids for chronic non-cancer pain without functional goals — SPACE and CDC 2022 argue against routine superiority of opioids
  • Opioid plus benzodiazepine (and often gabapentinoid) polypharmacy — overdose and dependence risk
  • Care-avoidant illness anxiety missing real disease because the patient refuses examinations
  • Factitious or malingering language without careful evidence — high medicolegal and alliance cost
  • Suicidality, severe depression, or opioid use disorder untreated while focusing only on 'somatisation'
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • New or changing focal neurological, constitutional, or red-flag pain features — re-open the organic work-up even in known somatising patients
  • Telling the patient 'it is all in your head' — destroys alliance and is nosologically wrong under DSM-5-TR SSD logic
  • Long-term high-dose opioids for chronic non-cancer pain without functional goals — SPACE and CDC 2022 argue against routine superiority of opioids
  • Opioid plus benzodiazepine (and often gabapentinoid) polypharmacy — overdose and dependence risk
  • Care-avoidant illness anxiety missing real disease because the patient refuses examinations
  • Factitious or malingering language without careful evidence — high medicolegal and alliance cost
  • Suicidality, severe depression, or opioid use disorder untreated while focusing only on 'somatisation'
The one-line answer

Somatic symptom disorder (SSD) is defined by distressing somatic symptoms plus disproportionate thoughts, feelings or behaviours — not by proving the symptoms are "medically unexplained." Illness anxiety disorder (IAD) is health-anxiety preoccupation with minimal somatic symptoms. Chronic pain work is a biopsychosocial C-L interface: validate symptoms, screen depression, anxiety, suicide and opioid risk, prefer CBT and function-focused care, use duloxetine or low-dose TCAs cautiously when indicated, and treat opioid use disorder as comorbidity care — never moralisation.[1][11][20][24]

Meet the patient

A 52-year-old woman has been admitted under the physicians for the fourth time this year. Each admission: chest pain, abdominal pain, dizziness, normal scans, and a discharge letter that reads medically unexplained — consider psychiatry. She arrives angry, clutching a folder of results, and tells you the last registrar said it was "all in her head."[4][24]

She takes oxycodone 40 mg a day, diazepam 10 mg at night, and has stopped working. Her PHQ-15 is high, her mood is low, and she has not slept properly in months.[4][20]

Two questions decide whether she gets better or returns a fifth time. Has anyone given her a positive explanation that doesn't call her a liar? And what is the function she has lost — and could regain? Everything below serves those two questions at consultant depth.[6][24]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References24ShowHide
  1. [1]Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM J Psychosom Res, 2013.PMID 23972410
  2. [2]Dimsdale JE, Levenson J What's next for somatic symptom disorder? Am J Psychiatry, 2013.PMID 24306336
  3. [3]Mayou R Is the DSM-5 chapter on somatic symptom disorder any better than DSM-IV somatoform disorder? Br J Psychiatry, 2014.PMID 25029686
  4. [4]Kroenke K, Spitzer RL, Williams JB The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms Psychosom Med, 2002.PMID 11914441
  5. [5]Kroenke K, Spitzer RL, Williams JB, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review Gen Hosp Psychiatry, 2010.PMID 20633738
  6. [6]Henningsen P, Zipfel S, Herzog W Management of functional somatic syndromes Lancet, 2007.PMID 17368156
  7. [7]Fink P, Toft T, Hansen MS, et al. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients Psychosom Med, 2007.PMID 17244846
  8. [8]van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults Cochrane Database Syst Rev, 2014.PMID 25362239
  9. [9]Kleinstäuber M, Witthöft M, Steffanowski A, et al. Pharmacological interventions for somatoform disorders in adults Cochrane Database Syst Rev, 2014.PMID 25379990
  10. [10]Kleinstäuber M, Witthöft M, Hiller W Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis Clin Psychol Rev, 2011.PMID 20920834
  11. [11]Barsky AJ, Ahern DK Cognitive behavior therapy for hypochondriasis: a randomized controlled trial JAMA, 2004.PMID 15039413
  12. [12]Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial Am J Psychiatry, 2007.PMID 17202549
  13. [13]Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial Lancet, 2014.PMID 24139977
  14. [14]Fallon BA, Ahern DK, Pavlicova M, et al. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis Am J Psychiatry, 2017.PMID 28659038
  15. [15]Barsky AJ, Ahern DK, Bauer MR, et al. A randomized trial of treatments for high-utilizing somatizing patients J Gen Intern Med, 2013.PMID 23494213
  16. [16]Sumathipala A, Siribaddana S, Abeysingha MR, et al. Cognitive-behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial Br J Psychiatry, 2008.PMID 18700219
  17. [17]Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults Cochrane Database Syst Rev, 2015.PMID 26146793
  18. [18]Lunn MP, Hughes RA, Wiffen PJ Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia Cochrane Database Syst Rev, 2014.PMID 24385423
  19. [19]Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy Pain, 2005.PMID 15927394
  20. [20]Krebs EE, Gravely A, Nugent S, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial JAMA, 2018.PMID 29509867
  21. [21]Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 MMWR Recomm Rep, 2022.PMID 36327391
  22. [22]Williams ACC, Fisher E, Hearn L, et al. Psychological therapies for the management of chronic pain (excluding headache) in adults Cochrane Database Syst Rev, 2020.PMID 32794606
  23. [23]Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial JAMA, 2009.PMID 19470987
  24. [24]Howe CQ, Sullivan MD The missing 'P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care Gen Hosp Psychiatry, 2014.PMID 24211157

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNormal pressure hydrocephalus and reversible dementiasConsultation-liaison psychiatryNextPalliative care psychiatryConsultation-liaison psychiatry